# Rosemary Sleep Quality Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/rosemary-sleep-quality-randomized-trial-evidence-review
Category: evidence-review
Summary: Rosemary Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-08-06
Reviewed by: Migaku Evidence Review
# Rosemary Sleep Quality Randomized Trial: What the Evidence Says

## Quick Answer

Rosemary Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Mobile health applications for enhancing mental health access and outcomes among adolescents and young people living with HIV: a systematic review | systematic review | 1 | 2026-05-06 | 10.1186/s12982-026-01998-9 |
| Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review | narrative review | 3 | 2026-01-14 | 10.3389/fphar.2026.1681709 |

## What The Sources Report

- Moreover, substance use, including alcohol and drug misuse, has emerged as both a coping mechanism and a risk factor that exacerbates MH problems and increases the likelihood of poor adherence to antiretroviral therapy (ART). [Muleya Carlos (2026); evidence level 1]
- Despite their growing popularity and demonstrated benefits, the empirical evidence on the effectiveness of these mHealth applications in improving access to MH services among AYPLHIV remains fragmented. [Muleya Carlos (2026); evidence level 1]
- However, traditional sedative-hypnotic medications such as benzodiazepines, while effective, are often associated with dependency and adverse effects (;;). [Ma Dongchuan (2026); evidence level 3]
- Frost et al., 2024 In summary, the prevalence of insomnia and its health implications prompt a reevaluation of the limitations associated with conventional pharmacotherapy. [Ma Dongchuan (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For rosemary sleep quality randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Muleya Carlos (2026). Mobile health applications for enhancing mental health access and outcomes among adolescents and young people living with HIV: a systematic review. DOI: 10.1186/s12982-026-01998-9. PMCID: PMC13149599. PMID: 42109762. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13149599/
- Ma Dongchuan (2026). Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review. DOI: 10.3389/fphar.2026.1681709. PMCID: PMC12847301. PMID: 41613780. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12847301/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.